STOCK TITAN
  1. Home
  2. Sec-filings
  3. EXOZ
  4. [EFFECT] EXOZYMES INC. SEC Filing

[EFFECT] EXOZYMES INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 23, 2026 4:30 P.M.
Form: S-3
CIK: 0002010788
Company Name: EXOZYMES INC.
File Number: 333-292781

Source: View Original Filing on SEC EDGAR

eXoZymes Inc

NASDAQ:EXOZ

View EXOZ Stock Overview →

EXOZ Rankings

#5465 Ranked by Market Cap
N/A Ranked by Dividends

EXOZ Latest News

Mar 18, 2026
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
Mar 12, 2026
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium
Feb 10, 2026
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation
Jan 29, 2026
eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run
Dec 11, 2025
eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion

EXOZ Latest SEC Filings

Feb 4, 2026
[8-K] EXOZYMES INC. Reports Material Event
Jan 26, 2026
[424B2] EXOZYMES INC. Prospectus Supplement
Jan 16, 2026
[S-3] EXOZYMES INC. Shelf Registration Statement
Dec 16, 2025
[S-8] EXOZYMES INC. Employee Benefit Plan Registration
Dec 11, 2025
[8-K] EXOZYMES INC. Reports Material Event

EXOZ Stock Data

61.99M
2.38M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
MONROVIA